Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Pathways of Eicosanoid Metabolism

NCT04464070 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT04464070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04464070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Pathways of Eicosanoid Metabolism
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
August 15, 2020
Completion date
August 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism of prostaglandin d2